{
  "ticker": "ILA",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02973333",
  "id": "02973333",
  "pages": 39,
  "price_sensitive": false,
  "date": "20250728",
  "time": "1322",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250728/pdf/06m6qmcqtqvjrk.pdf",
  "summary": "### Summary of Material Information:\n\n#### **Corporate Overview:**\n- **Market Cap (as of 28 July 2025):** AUD $37.1M  \n- **Cash Balance (30 June 2025):** AUD $7.25M  \n- **Key Shareholders:** Dr. William James Garner (16.86%), Jason Alan Carroll (12.58%), MWP Partners (7.79%), Dr. Daniel Tillett (5.71%).  \n\n#### **Clinical Programs:**\n1. **ISLA-101 (Dengue Fever):**  \n   - Completed Phase 2a/b trial (PROTECT) with **positive top-line results**:  \n     - Reduced viral load (10-15x lower peak RNA) in prophylactic cohort.  \n     - Shorter duration of viremia vs. control (8.5 vs. 10.5 days).  \n   - **Potential Priority Review Voucher (PRV)** eligibility upon FDA approval.  \n   - No approved treatments currently exist for dengue (market potential: multi-billion USD).  \n\n2. **Galidesivir (Broad-Spectrum Antiviral):**  \n   - Targets Marburg, Ebola, Zika, and other RNA viruses.  \n   - **FDA Animal Rule Pathway**: Potential approval based on animal efficacy data (non-human primate studies).  \n   - Planned **Marburg animal study completion** by Q4 2025.  \n   - PRV eligibility in multiple indications (recent PRVs valued at $103M\u2013$158M).  \n\n#### **Near-Term Catalysts:**  \n- **Galidesivir transaction completion**: August 2025.  \n- **FDA meetings** (Galidesivir Animal Rule, ISLA-101 protocols): Q4 2025.  \n- **Marburg animal study initiation/completion**: Q4 2025.  \n\n#### **Investor Engagement:**  \n- **Roadshow**: 30 July\u20135 August 2025 (Australia).  \n- **Bioshares Biotech Summit**: 7\u20138 August 2025 (Hobart).  \n\nNo material capital raising, financial changes, or liquidity events disclosed.",
  "usage": {
    "prompt_tokens": 7606,
    "completion_tokens": 449,
    "total_tokens": 8055,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-28T03:34:50.043651"
}